<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:ifp="http://www.ifactory.com/press" ifp-element-xpath="/*[local-name() = 'urlset' and namespace-uri() = 'http://www.sitemaps.org/schemas/sitemap/0.9']"><ifp:contentType>ARTICLE</ifp:contentType><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p284.xml</sm:loc><ifp:title>Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p284.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pxxxiii.xml</sm:loc><ifp:title>NCCN News</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pxxxiii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN News</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p277.xml</sm:loc><ifp:title>Saying Yes</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p277.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Saying Yes</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pliii.xml</sm:loc><ifp:title>Re: An Oncologist's Letter to Santa</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pliii.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Re: An Oncologist's Letter to Santa</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pxli.xml</sm:loc><ifp:title>Oncology Research Program</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-pxli.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Oncology Research Program</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p293.xml</sm:loc><ifp:title>NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p293.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p370.xml</sm:loc><ifp:title>Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p370.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p346.xml</sm:loc><ifp:title>Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p346.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p355.xml</sm:loc><ifp:title>Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p355.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p336.xml</sm:loc><ifp:title>Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p336.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p316.xml</sm:loc><ifp:title>Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p316.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p327.xml</sm:loc><ifp:title>Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p327.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p411.xml</sm:loc><ifp:title>Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p411.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p401.xml</sm:loc><ifp:title>An Expanding Role for Immunotherapy in Colorectal Cancer</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p401.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>An Expanding Role for Immunotherapy in Colorectal Cancer</ifp:title></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p421.xml</sm:loc><ifp:title>Equity in Precision Medicine: Is It Within Our Reach?</ifp:title><sm:lastmod>2026-04-18</sm:lastmod></sm:url><sm:url xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9"><sm:loc>https://harbor.dev.pubfactory.com/view/journals/jnccn/15/3/article-p421.pdf</sm:loc><sm:lastmod>2026-04-18</sm:lastmod><ifp:title>Equity in Precision Medicine: Is It Within Our Reach?</ifp:title></sm:url></urlset>
